Show Search Form

Search Results

registered interest	true false
date	exactly: or between: and
answering body
answering dept id
answering dept short name
answering dept sort name
hansard heading
house id
legislature	pref label
question text
tabling member constituency
tabling member printed
uin
answer	is ministerial correction true false date of answer exactly: or between: and answer text answering member constituency answering member printed grouped question UIN question first answered answering member label
tabling member	label

Search

1060850

	registered interest
	date	13/02/2019
	answering body	Department of Health and Social Care
	answering dept id	17
	answering dept short name	Health and Social Care
	answering dept sort name	Health and Social Care
	hansard heading	Air Pollution: Children
	house id	1
	legislature	25259 pref label House of Commons
	question text	To ask the Secretary State for Health and Social Care, what assessment he has made of the effect of toxic air on children’s health.
	tabling member constituency	Scunthorpe
	tabling member printed	Nic Dakin
	uin	220891
	answer	answer is ministerial correction date of answer 18/02/2019 answer text <p>Poor air quality is the largest environmental risk to public health in the United Kingdom. Long-term exposure to air pollution can cause chronic conditions such as cardiovascular, respiratory diseases and cancer, leading to reduced life expectancy.</p><p> </p><p>Air pollution has a particular impact on children as they grow. There is evidence that the process of normal lung function growth in children is suppressed by long-term exposure to air pollution.</p><p> </p><p>The effects of air pollution on children’s health are being studied in research projects. The EXHALE Programme is a London study on air pollution and children’s lung health. The Committee on the Medical Effects of Air Pollutants has started work to consider the evidence for the effects of air pollution on adverse birth outcomes. The Royal College of Paediatrics and Child Health is working on a report on ‘Indoor Air Quality on Children and Young People’s Health across the Life Course’.</p> answering member constituency Winchester answering member printed Steve Brine question first answered 18/02/2019 17:13:48 answering member 4067 label Biography information for Steve Brine
	tabling member	4056 label Biography information for Nic Dakin

1054660

	registered interest
	date	04/02/2019
	answering body	Department of Health and Social Care
	answering dept id	17
	answering dept short name	Health and Social Care
	answering dept sort name	Health and Social Care
	hansard heading	Cerliponase Alfa
	house id	1
	legislature	25259 pref label House of Commons
	question text	To ask the Secretary of State for Health and Social Care, if he will hold meetings with families of children with ceroid lipofuscinosis type 2 disease on the availability of Brineura on the NHS.
	tabling member constituency	Leeds North West
	tabling member printed	Alex Sobel
	uin	216384
	answer	answer is ministerial correction date of answer 12/02/2019 answer text <p>The Department has no plans currently. The National Institute for Health and Care Excellence is currently developing guidance on Brineura (Cerliponase alfa) for treating neuronal ceroid lipofuscinosis type 2 under the highly specialised technology programme. Further information can be found at the following link:</p><p> </p><p><a href="https://www.nice.org.uk/guidance/indevelopment/gid-hst10008" target="_blank">https://www.nice.org.uk/guidance/indevelopment/gid-hst10008</a></p> answering member constituency Winchester answering member printed Steve Brine question first answered 12/02/2019 15:49:07 answering member 4067 label Biography information for Steve Brine
	tabling member	4658 label Biography information for Alex Sobel

1050056

	registered interest
	date	28/01/2019
	answering body	Department of Health and Social Care
	answering dept id	17
	answering dept short name	Health and Social Care
	answering dept sort name	Health and Social Care
	hansard heading	Air Pollution
	house id	1
	legislature	25259 pref label House of Commons
	question text	To ask the Secretary of State for Health and Social Care, pursuant to his Answer of 15 October 2018 to Question 174612, Air Pollution, as the COMEAP study to which he refers was carried out in 2012, if he will (a) ask that body to conduct a further study on the effects of particulate air pollution on mortality in the UK and (b) will ensure that such a new study includes PM0.1 and PM1.
	tabling member constituency	Stroud
	tabling member printed	Dr David Drew
	uin	213200
	answer	answer is ministerial correction date of answer 05/02/2019 answer text <p>Recent assessments have been undertaken of the health effects of long-term exposure to the air pollution mixture in the United Kingdom, based on studies reporting associations of mortality risk with fine particulate matter (PM2.5), which includes PM1 and PM0.1, and nitrogen dioxide (NO<sub>2</sub>). No separate assessments of the impact of the PM1 and PM0.1 components (particulate matter with an aerodynamic diameter smaller than 1 or 0.1 microns respectively) of particulate air pollution have been produced. The recent Committee on the Medical Effects of Air Pollutants assessment is available to view at the following link:</p><p> </p><p><a href="https://www.gov.uk/government/publications/nitrogen-dioxide-effects-on-mortality" target="_blank">https://www.gov.uk/government/publications/nitrogen-dioxide-effects-on-mortality</a></p><p> </p><p>The reviews by the Health Effects Institute and World Health Organization of the effects of different components of air pollution, including ultrafine particles (PM0.1), concluded that there is currently limited evidence on the effects on health of ultrafine particles. These reviews are available at the following links:</p><p> </p><p><a href="https://www.healtheffects.org/publication/understanding-health-effects-ambient-ultrafine-particles" target="_blank">https://www.healtheffects.org/publication/understanding-health-effects-ambient-ultrafine-particles</a></p><p> </p><p><a href="http://www.euro.who.int/__data/assets/pdf_file/0004/193108/REVIHAAP-Final-technical-report-final-version.pdf?ua=1" target="_blank">http://www.euro.who.int/__data/assets/pdf_file/0004/193108/REVIHAAP-Final-technical-report-final-version.pdf?ua=1</a></p><p> </p><p>Currently, Public Health England has no plans to engage in work on the effects of PM1 and PM0.1 particles on human health.</p> answering member constituency Winchester answering member printed Steve Brine question first answered 05/02/2019 15:19:38 answering member 4067 label Biography information for Steve Brine
	tabling member	252 label Biography information for Dr David Drew

1010226

	registered interest
	date	19/11/2018
	answering body	Department of Health and Social Care
	answering dept id	17
	answering dept short name	Health and Social Care
	answering dept sort name	Health and Social Care
	hansard heading	Incinerators: Health Hazards
	house id	1
	legislature	25259 pref label House of Commons
	question text	To ask the Secretary of State for Health and Social Care, what recent research he has (a) commissioned and (b) considered of the effects on human health of municipal waste incinerators on people living within (i) 0.5 kilometre, (ii) 0.9 kilometre, (iii) 1 kilometre, (iv) 2 kilometres and (v) 5 kilometres of those incinerators.
	tabling member constituency	Stroud
	tabling member printed	Dr David Drew
	uin	192711
	answer	answer is ministerial correction date of answer 27/11/2018 answer text <p>Public Health England (PHE) funded the Small Area Health Statistics Unit, and King’s College London, to carry out a study to further extend the evidence base as to whether emissions from modern municipal waste incinerators affect human health.</p><p> </p><p>The first of a series of papers from this study was published on 22 November 2018. The paper ‘Fetal growth, stillbirth, infant mortality and other birth outcomes near UK municipal waste incinerators; retrospective population based cohort and case-control study’ is available to view at the following link:</p><p> </p><p><a href="https://www.sciencedirect.com/science/article/pii/S0160412018316398" target="_blank">https://www.sciencedirect.com/science/article/pii/S0160412018316398</a></p><p> </p><p>The paper found no evidence of a link between exposure to particulate matter emitted from modern municipal waste incinerators as modelled from emissions data, or living close to modern municipal waste incinerators, and infant mortality, low birth weight, still birth or the other birth outcomes investigated.</p><p> </p><p>PHE’s position is that well run and regulated modern municipal waste incinerators are not a significant risk to public health. PHE will review its advice in light of new substantial research on the health effects of incinerators published in peer reviewed journals. To date, PHE is not aware of any evidence that requires a change in their position statement.</p> answering member constituency Winchester answering member printed Steve Brine grouped question UIN 192712 question first answered 27/11/2018 17:09:00 answering member 4067 label Biography information for Steve Brine
	tabling member	252 label Biography information for Dr David Drew

1007006

	registered interest
	date	14/11/2018
	answering body	Department of Health and Social Care
	answering dept id	17
	answering dept short name	Health and Social Care
	answering dept sort name	Health and Social Care
	hansard heading	Ovarian Cancer
	house id	1
	legislature	25259 pref label House of Commons
	question text	To ask the Secretary of State for Health and Social Care, what recent steps his Department has taken to improve early diagnosis of ovarian cancer.
	tabling member constituency	Birkenhead
	tabling member printed	Frank Field
	uin	191308
	answer	answer is ministerial correction date of answer 22/11/2018 answer text <p>Public Health England (PHE) has run a number of ‘Be Clear on Cancer’ (BCOC) campaigns to help improve early detection of cancer. In 2014 PHE ran a regional ovarian cancer campaign in the North West of England, and in 2017 a pilot which focussed on a range of abdominal symptoms, such as diarrhoea, bloating and discomfort that can be indicative of a number of cancers, including ovarian cancer was carried out in the East and West Midlands. PHE is currently undertaking new data analysis and research to determine the future direction of BCOC activity in 2019/20 and will take into consideration the outcomes of these previous campaigns. PHE will also consult with NHS England on the timings and location of any future campaigns.</p> answering member constituency Winchester answering member printed Steve Brine question first answered 22/11/2018 11:44:06 answering member 4067 label Biography information for Steve Brine
	tabling member	478 label Biography information for Lord Field of Birkenhead

1006075

	registered interest
	date	13/11/2018
	answering body	Department of Health and Social Care
	answering dept id	17
	answering dept short name	Health and Social Care
	answering dept sort name	Health and Social Care
	hansard heading	Prescription Drugs
	house id	1
	legislature	25259 pref label House of Commons
	question text	To ask the Secretary of State for Health and Social Care, whether a non-disclosure agreement was made between Public Health England and the National Guideline Centre in relation to the review of literature on prescribed medicines.
	tabling member constituency	Lancaster and Fleetwood
	tabling member printed	Cat Smith
	uin	190914
	answer	answer is ministerial correction date of answer 20/11/2018 answer text <p>‘Prescribed Medicines: An Evidence Review’ is a public health evidence review of the published evidence and available data. This process is distinct from a public inquiry so the inclusion of individual testimonies would not be appropriate.</p><p> </p><p>Public Health England (PHE) is aware of the importance and relevance of the experience of patients in understanding the issues. The review will give significant prominence to the patients’ experiences and examine existing service models through published research and other methods, for example analysis of annual reports of various withdrawal charities.</p><p> </p><p>The call for evidence was open to all parties, including pharmaceutical companies. The call for evidence has now closed. The National Guideline Centre (NGC) will provide details on the evidence submitted in their rapid evidence assessment report. The report is due in early 2019.</p><p> </p><p>A non-disclosure agreement was not made between PHE and the NGC in relation to the review of literature on prescribed medicines.</p> answering member constituency Winchester answering member printed Steve Brine grouped question UIN 190913 question first answered 20/11/2018 15:07:46 answering member 4067 label Biography information for Steve Brine
	tabling member	4436 label Biography information for Cat Smith

1051475

	registered interest
	date	30/01/2019
	answering body	Department of Health and Social Care
	answering dept id	17
	answering dept short name	Health and Social Care
	answering dept sort name	Health and Social Care
	hansard heading	HIV Infection: Drugs
	house id	1
	legislature	25259 pref label House of Commons
	question text	To ask the Secretary of State for Health and Social Care, by what date the proposed doubling of places on its PrEP Impact Trial will be achieved.
	tabling member constituency	Liverpool, Wavertree
	tabling member printed	Luciana Berger
	uin	214543
	answer	answer is ministerial correction date of answer 04/02/2019 answer text <p>On 30 January, the Secretary of State for Health and Social Care announced that the Pre-exposure Prophylaxis (PrEP) Impact trial would be expanded to 26,000 people. Work is underway with partners to take this forward. The PrEP Oversight Board has requested information on local capacity to make the additional places available, and will review this later in February. The Secretary of State also announced the Government’s commitment to ending new HIV transmissions in England by 2030. To support this work, an expert group will be established to develop an action plan over the course of this year. The important role of PrEP, as part of combination HIV prevention efforts, will be considered as part of this process.</p> answering member constituency Winchester answering member printed Steve Brine grouped question UIN 214541 214542 question first answered 04/02/2019 18:09:57 answering member 4067 label Biography information for Steve Brine
	tabling member	4036 label Biography information for Luciana Berger

1063647

	registered interest
	date	18/02/2019
	answering body	Department of Health and Social Care
	answering dept id	17
	answering dept short name	Health and Social Care
	answering dept sort name	Health and Social Care
	hansard heading	GP at Hand: Birmingham
	house id	1
	legislature	25259 pref label House of Commons
	question text	To ask the Secretary of State for Health and Social Care, for what reason NHS England lifted the ban on the Babylon GP at Hand plans to expand into Birmingham before the independent evaluation by IPOS Mori of that service is published next month.
	tabling member constituency	Birmingham, Selly Oak
	tabling member printed	Steve McCabe
	uin	222634
	answer	answer is ministerial correction date of answer 21/02/2019 answer text <p>NHS England has considered the expansion of the service to Birmingham following initial concerns, in particular regarding access to immunisation and screening programmes for Babylon GP at Hand patients, and a solution has been identified. NHS England will now work together with NHS Hammersmith and Fulham and Birmingham and Solihull Clinical Commissioning Groups (CCGs), national screening services, and Babylon GP at Hand to mobilise the service and agree a start date.</p><p>General practice payments are made to practices according to their registered patient list size, so the funding for general practice care will follow the patients. NHS England will shortly engage on changes to out of area registration rules, some of the current payments to primary care providers and the mechanisms by which new providers can enter the market.</p><p>The new General Practitioner Contract Framework made two changes to the current payment system:</p><p>- the rurality index payment will be amended to apply to patients living within a practice catchment area only, rather than to all patients. This is to better reflect costs; and</p><p>- the London adjustment will be amended to apply to patients resident in London, rather than registered with a London-based practice</p><p> </p><p>CCG allocations have been revised for 2019/20. Hammersmith and Fulham CCG’s allocation takes account of the increased list size of the GP at Hand practice, with the CCG’s funding growth determined by an assessment of the CCG’s fair share of overall funding and rules on the pace of change in funding allocations.</p><p> </p><p>All patients registered with the Babylon GP at Hand practice are recorded as patients of Hammersmith and Fulham CCG.</p><p> </p><p>Hammersmith and Fulham CCG have commissioned an independent evaluation of the Babylon GP at Hand practice. This will look at the impact of the service on patient experience, primary care workforce, use of other services, such as accident and emergency departments and walk-in centres, and system value.</p><p> </p><p>Babylon GP at Hand will provide physical premises in both London and Birmingham for those patients who require a face-to-face consultation. Under the current GP of Choice Policy, the CCGs where ‘out of area’ patients live are required to ensure out of hours care and home visits can be accessed by those patients in their resident area if they need it.</p> answering member constituency Winchester answering member printed Steve Brine grouped question UIN 222635 222637 222638 222639 222640 question first answered 21/02/2019 16:24:56 answering member 4067 label Biography information for Steve Brine
	tabling member	298 label Biography information for Steve McCabe

1064339

	registered interest
	date	20/02/2019
	answering body	Department of Health and Social Care
	answering dept id	17
	answering dept short name	Health and Social Care
	answering dept sort name	Health and Social Care
	hansard heading	HIV Infection: Drugs
	house id	1
	legislature	25259 pref label House of Commons
	question text	To ask the Secretary of State for Health and Social Care, for what reason there has been a delay in doubling the number of places on the PrEP Trial across all trial sites.
	tabling member constituency	Salford and Eccles
	tabling member printed	Rebecca Long Bailey
	uin	223813
	answer	answer is ministerial correction date of answer 28/02/2019 answer text <p>My Rt. hon. Friend the Secretary of State for Health and Social Care announced on 30 January 2019 that the pre-exposure prophylaxis (PrEP) Impact trial would be expanded to 26,000 people. Work is currently underway with partners to take this forward. The PrEP Oversight Board has requested information on local capacity to make the additional places available, and will review this shortly. Further details on the timescale for implementation will be confirmed in due course.</p><p> </p><p>The Department has made no assessment of the effect of the closure of Shine in Salford. This is a matter for local commissioners.</p> answering member constituency Winchester answering member printed Steve Brine grouped question UIN 223806 223808 223814 question first answered 28/02/2019 11:54:14 answering member 4067 label Biography information for Steve Brine
	tabling member	4396 label Biography information for Rebecca Long Bailey

1020321

	registered interest
	date	05/12/2018
	answering body	Department of Health and Social Care
	answering dept id	17
	answering dept short name	Health and Social Care
	answering dept sort name	Health and Social Care
	hansard heading	Cervical Cancer: Screening
	house id	1
	legislature	25259 pref label House of Commons
	question text	To ask the Secretary of State for Health and Social Care, for what reason there has been a recent decline in the level of cervical screening attendance.
	tabling member constituency	Kingston upon Hull North
	tabling member printed	Diana Johnson
	uin	199347
	answer	answer is ministerial correction date of answer 10/12/2018 answer text <p>NHS England has reviewed the data from 2013 showing the continuing gradual national and international decline in the five-year coverage. Assessments for the decline were done in partnership with key stakeholders Public Health England (PHE) and Jo’s Cervical Cancer Trust.</p><p> </p><p>NHS England hosted a spotlight session in April 2016 which focussed on gaining insight into the reasons why women do or do not attend for screening. This suggested that ease of access together with attitudinal changes to informed choice, may contribute to this widespread reduction in uptake.</p><p> </p><p>Jo’s Cervical Cancer Trust published a report in January 2018 suggesting that some young women did not attend cervical screening appointments because they were embarrassed about their body, while others did not think the test was important and were not at risk because they led healthy lifestyles.</p><p> </p><p>NHS England and PHE have therefore modified the commissioning levers and communication processes, for example through supporting Jo’s Trust in the Time to Screen campaign and the development of a new ‘Be Clear on Cancer’ campaign for early 2019 promoting uptake of cervical screening.</p><p> </p><p>NHS England has supported the Cancer Alliances who bring together local senior clinical and managerial leaders representing the whole cancer patient pathway across a specific geography, and have a general role in improving early diagnosis. In turn they have developed specific plans to improve uptake rates in screening programmes as part of that agenda with cervical screening considered a priority area.</p><p> </p><p>Cancer Research UK (CRUK) and Macmillan general practitioners (GPs) are also being utilised to provide awareness and training, with work and focus groups to target reducing inequalities among women over 50 and women from Eastern European countries a specific focus in one region. The role that sexual health clinics can play in providing access to screening among vulnerable women via an opportunistic offer of screening is being considered.</p><p> </p><p>Training of GP receptionists is underway to improve ease of access to a screening appointment, while a toolkit has been developed to reduce the inequality in uptake among women with a learning disability.</p><p> </p><p>In addition, NHS England recently announced that Professor Sir Mike Richards has been asked to lead a review of cancer screening programmes which will consider ways to increase uptake of cervical screening.</p> answering member constituency Winchester answering member printed Steve Brine grouped question UIN 199346 question first answered 10/12/2018 15:34:24 answering member 4067 label Biography information for Steve Brine
	tabling member	1533 label Biography information for Dame Diana Johnson